353 related articles for article (PubMed ID: 15281114)
1. Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII.
Kelley BD; Tannatt M; Magnusson R; Hagelberg S; Booth J
Biotechnol Bioeng; 2004 Aug; 87(3):400-12. PubMed ID: 15281114
[TBL] [Abstract][Full Text] [Related]
2. Application of a novel affinity adsorbent for the capture and purification of recombinant factor VIII compounds.
McCue JT; Selvitelli K; Walker J
J Chromatogr A; 2009 Nov; 1216(45):7824-30. PubMed ID: 19800068
[TBL] [Abstract][Full Text] [Related]
3. Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.
Oh HK; Lee JM; Byun TH; Park SY; Kim YH
Biotechnol Prog; 2001; 17(6):1119-27. PubMed ID: 11735450
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a peptide ligand for affinity purification of factor VIII using phage display.
Kelley BD; Booth J; Tannatt M; Wub QL; Ladner R; Yuc J; Potter D; Ley A
J Chromatogr A; 2004 Jun; 1038(1-2):121-30. PubMed ID: 15233528
[TBL] [Abstract][Full Text] [Related]
5. Development of a peptidomimetic ligand for efficient isolation and purification of factor VIII via affinity chromatography.
Knör S; Khrenov AV; Laufer B; Saenko EL; Hauser CA; Kessler H
J Med Chem; 2007 Sep; 50(18):4329-39. PubMed ID: 17691762
[TBL] [Abstract][Full Text] [Related]
6. A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein A chromatography.
Zhang M; Lute S; Norling L; Hong C; Safta A; O'Connor D; Bernstein LJ; Wang H; Blank G; Brorson K; Chen Q
Biotechnol Bioeng; 2009 Apr; 102(5):1438-47. PubMed ID: 18988264
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
[TBL] [Abstract][Full Text] [Related]
8. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry.
Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M
Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A.
Nord K; Nord O; Uhlén M; Kelley B; Ljungqvist C; Nygren PA
Eur J Biochem; 2001 Aug; 268(15):4269-77. PubMed ID: 11488921
[TBL] [Abstract][Full Text] [Related]
10. Immobilised peptide displaying phages as affinity ligands. Purification of lactoferrin from defatted milk.
Noppe W; Plieva FM; Galaev IY; Vanhoorelbeke K; Mattiasson B; Deckmyn H
J Chromatogr A; 2006 Jan; 1101(1-2):79-85. PubMed ID: 16216254
[TBL] [Abstract][Full Text] [Related]
11. Novel peptide ligand with high binding capacity for antibody purification.
Lund LN; Gustavsson PE; Michael R; Lindgren J; Nørskov-Lauritsen L; Lund M; Houen G; Staby A; St Hilaire PM
J Chromatogr A; 2012 Feb; 1225():158-67. PubMed ID: 22251884
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
[TBL] [Abstract][Full Text] [Related]
13. Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics.
Strauss DM; Lute S; Tebaykina Z; Frey DD; Ho C; Blank GS; Brorson K; Chen Q; Yang B
Biotechnol Bioeng; 2009 Oct; 104(2):371-80. PubMed ID: 19575414
[TBL] [Abstract][Full Text] [Related]
14. Screening for peptide affinity ligands on CIM monoliths.
Pflegerl K; Podgornik A; Berger E; Jungbauer A
Biotechnol Bioeng; 2002 Sep; 79(7):733-40. PubMed ID: 12209796
[TBL] [Abstract][Full Text] [Related]
15. Affinity chromatography matures as bioinformatic and combinatorial tools develop.
Clonis YD
J Chromatogr A; 2006 Jan; 1101(1-2):1-24. PubMed ID: 16242704
[TBL] [Abstract][Full Text] [Related]
16. Single step purification of plasmid DNA using peptide ligand affinity chromatography.
Han Y; Forde GM
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):21-6. PubMed ID: 18815078
[TBL] [Abstract][Full Text] [Related]
17. [Development of a new hydrophobic interaction chromatography absorbent and its application to the purification of recombinant hepatitis B surface antigen].
Wang YM; Bi JX; Zhao L; Zhou WB; Li Y; Huang YD; Zhang Y; Lin H; Su ZG
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):278-84. PubMed ID: 16607957
[TBL] [Abstract][Full Text] [Related]
18. Weak partitioning chromatography for anion exchange purification of monoclonal antibodies.
Kelley BD; Tobler SA; Brown P; Coffman JL; Godavarti R; Iskra T; Switzer M; Vunnum S
Biotechnol Bioeng; 2008 Oct; 101(3):553-66. PubMed ID: 18727127
[TBL] [Abstract][Full Text] [Related]
19. Use of ceramic monoliths as stationary phase in affinity chromatography.
Martin del Valle E; Galan Serrano MA; Cerro RL
Biotechnol Prog; 2003; 19(3):921-7. PubMed ID: 12790658
[TBL] [Abstract][Full Text] [Related]
20. Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.
Farrugia A
Australas Biotechnol; 1993; 3(1):16-20. PubMed ID: 7763537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
